|
(11) Diet Modification to Augment Radiation for Breast Cancer Brain Metastases
|
1R01CA227479-01
|
$351,726
|
$351,726
|
SIMONE, NICOLE
|
THOMAS JEFFERSON UNIVERSITY
|
|
(7) Novel imaging devices for measurement and control of tumor microenvironments
|
5R01CA216248-02
|
$607,904
|
$607,904
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
(PQ #10) Gut-brain interactions underlying chemotherapy-induced behavioral comorbidities
|
5R01CA216290-02
|
$309,819
|
$309,819
|
PYTER, LEAH
|
OHIO STATE UNIVERSITY
|
|
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.
|
3R01CA206025-03S1
|
$52,355
|
$52,355
|
GUISE, THERESA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.
|
5R01CA206025-03
|
$630,724
|
$630,724
|
GUISE, THERESA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
(PQ3) Cellular and Molecular Mechanisms Driving Myeloid Compartment Variation in Human Triple Negative Breast Cancer
|
5R01CA219880-02
|
$670,182
|
$670,182
|
PALUCKA, ANNA KAROLINA
|
JACKSON LABORATORY
|
|
(PQ5) Consequences of imbalanced mitophagy and mitochondrial biogenesis in cancer
|
5R01CA216242-02
|
$319,238
|
$319,238
|
MACLEOD, KAY
|
UNIVERSITY OF CHICAGO
|
|
(PQ6) Molecular Mechanisms Driving Benign to Malignant Transitions in Breast Cancer
|
5R01CA205632-03
|
$457,974
|
$457,974
|
RIEGEL, ANNA
|
GEORGETOWN UNIVERSITY
|
|
(PQ7) Quantitative in vivo optical imaging of tumor heterogeneity
|
5R01CA205101-03
|
$384,612
|
$384,612
|
SKALA, MELISSA
|
MORGRIDGE INSTITUTE FOR RESEARCH, INC.
|
|
(PQ9) A NOVEL MECHANISM OF PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY AND POTENTIAL TREATMENT
|
5R01CA208765-03
|
$343,846
|
$343,846
|
YANG, QING
|
UNIVERSITY OF TEXAS MED BR GALVESTON
|
|
(PQ9) Developing EZH2 Degraders for Treating Triple-Negative Breast Cancer
|
1R01CA230854-01
|
$249,841
|
$249,841
|
JIN, JIAN
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
(PQ9) The role of Bclw (bcl2l2) in preventing chemotherapy induced neuropathy
|
5R01CA205255-03
|
$577,463
|
$577,463
|
SEGAL, ROSALIND
|
DANA-FARBER CANCER INST
|
|
(PQA5) Dose and Mechanisms of Exercise in Breast Cancer Prevention
|
5R01CA179992-05
|
$648,503
|
$648,503
|
JONES, LEE
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
(PQC3) Ethnicity-determined immune response and DCIS outcome
|
5R01CA194600-04
|
$179,518
|
$179,518
|
BADVE, SUNIL
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
(PQD-3) Spatiotemporal Molecular Interrogation of Early Metastatic Evolution In Situ
|
5R01CA194697-04
|
$347,700
|
$347,700
|
ZHANG, SIYUAN
|
UNIVERSITY OF NOTRE DAME
|
|
1/2 Southeast Partnership for Improving Research & Training in Cancer Health Disparities
|
5P20CA202920-02
|
$301,538
|
$301,538
|
MEADE, CATHY
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
1/2 The GUIDE Cancer Research Training Project
|
5P20CA202908-04
|
$186,883
|
$186,883
|
WINN, ROBERT
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
2/2 Southeast Partnership for Improving Research & Training in Cancer Health Disparities
|
5P20CA202922-02
|
$242,408
|
$242,408
|
MIELE, LUCIO
|
LSU HEALTH SCIENCES CENTER
|
|
2/2 The GUIDE Cancer Research Training Project
|
5P20CA202907-04
|
$204,897
|
$204,897
|
BALTHAZAR, CATHERINE
|
GOVERNORS STATE UNIVERSITY
|
|
3-D modeling-based decision support for optimizing quality of life following breast reconstruction
|
5R01CA203984-03
|
$669,662
|
$669,662
|
MARKEY, MIA
|
UNIVERSITY OF TEXAS, AUSTIN
|
|
3-Dimensional profile of circulating miRNA for early cancer detection
|
5R01CA188991-04
|
$303,506
|
$303,506
|
ZHONG, WENWAN
|
UNIVERSITY OF CALIFORNIA RIVERSIDE
|
|
A biophysical stromal basis for radiation sensitivity in ductal carcinoma in situ
|
5R01CA174929-05
|
$570,235
|
$570,235
|
PARK, CATHERINE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
A Biopsychosocial Approach to Behavioral Oncology in Young Adults
|
5F99CA222727-02
|
$32,259
|
$32,259
|
DARABOS, KATHLEEN
|
HUNTER COLLEGE
|
|
A Circulating Biomarker for use in Monitoring Metastatic Breast Cancer
|
2R44CA210817-02
|
$1,101,350
|
$1,101,350
|
SERRERO, GINETTE
|
A AND G PHARMACEUTICAL, INC.
|
|
A comprehensive liquid biopsy platform for detection and prognostication in early stage breast cancer
|
1U01CA233363-01
|
$587,514
|
$587,514
|
COTE, RICHARD
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
A mechanistic dissection of the role of Eya3 in breast cancer metastasis
|
1F99CA234940-01
|
$36,490
|
$36,490
|
ZHOU, HENGBO
|
UNIVERSITY OF COLORADO DENVER
|
|
A Microfluidics Approach to Investigate Tumor Cell Trafficking in Bone Marrow
|
5F32CA210540-02
|
$61,174
|
$61,174
|
GLASER, DREW
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
A microRNA mediating vascular directed fibrinolysis and tumor progression
|
5F31CA213793-03
|
$33,794
|
$33,794
|
MCCANN, JAMES
|
UNIVERSITY OF VIRGINIA
|
|
A multiplexed approach to improve tumoral targeting and chemotherapeutic treatment
|
1R01CA222802-01A1
|
$412,139
|
$412,139
|
LAW, BENEDICT
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
A nanosystem for tumor treatment and imaging
|
5R01CA188883-05
|
$404,625
|
$404,625
|
RUOSLAHTI, ERKKI
|
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST
|
|
A Non-Contact Optical Patient and Beam Dosimetry System for Continuous in vivo Radiotherapy Verification
|
1R44CA232879-01
|
$252,666
|
$252,666
|
WARE, WILLIAM
|
DOSEOPTICS, LLC
|
|
A Novel Anti-HER2/neu IgE for Breast Cancer Therapy
|
5R01CA181115-05
|
$592,761
|
$592,761
|
PENICHET, MANUEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
A Novel Clinically Relevant Tumor Suppressor in Human Breast Cancer
|
1R03CA223709-01A1
|
$77,255
|
$77,255
|
SPINELLA, MICHAEL
|
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
|
|
A Novel Immunotherapy Targeting Cancer Stem Cells for the Treatment of Triple-Negative Breast Cancer
|
1R44CA224835-01A1
|
$298,864
|
$298,864
|
PERICLE, FEDERICA
|
AGILVAX, INC.
|
|
A Novel LGR4 Oncogenic Signaling in Breast Cancer Progression and Metastasis
|
5R01CA204926-02
|
$362,569
|
$362,569
|
LI, YI
|
BAYLOR COLLEGE OF MEDICINE
|
|
A novel N-Ras pathway driving DCIS to basal-like breast cancer
|
1R21CA226567-01
|
$212,055
|
$212,055
|
CHANG, ERIC
|
BAYLOR COLLEGE OF MEDICINE
|
|
A novel regulator of triple negative breast cancer and breast cancer stem cell phenotype
|
1R03CA223946-01
|
$79,750
|
$79,750
|
DIMRI, MANJARI
|
GEORGE WASHINGTON UNIVERSITY
|
|
A novel target to overcome chemoresistance in breast cancer
|
1R21CA223389-01
|
$203,580
|
$203,580
|
RINCON, MERCEDES
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
|
A Novel Values-based Intervention to Increase Endocrine Therapy Adherence among Breast Cancer Survivors
|
1R21CA218723-01A1
|
$207,450
|
$207,450
|
ARCH, JOANNA
|
UNIVERSITY OF COLORADO
|
|
A partnership to enable clinical ctDNA testing for breast cancer recurrence
|
5R01CA204253-03
|
$472,123
|
$472,123
|
VARLEY, KATHERINE
|
UNIVERSITY OF UTAH
|
|
A Phase 2 clinical trial of topical uracil for the prevention of capecitabine induced hand-foot syndrome
|
5R44CA213519-02
|
$1
|
$1
|
ISAACMAN, STEVEN
|
NANOMETICS, LLC
|
|
A Phase III Randomized Trial Targeting Behavioral Symptoms in Younger Breast Cancer Survivors
|
5R01CA200977-03
|
$639,777
|
$639,777
|
GANZ, PATRICIA
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
A population-based approach to single CTC analysis in metastatic breast cancer outcome
|
5R01CA207468-02
|
$587,218
|
$587,218
|
YANG, HUSHAN
|
THOMAS JEFFERSON UNIVERSITY
|
|
A precision medicine basis for estrogen therapy for advanced breast cancer
|
5R01CA200994-02
|
$370,575
|
$370,575
|
MILLER, TODD
|
DARTMOUTH COLLEGE
|
|
A prospective examination of change in executive function and physical activity in older breast cancer survivors.
|
1F31CA220964-01A1
|
$42,314
|
$42,314
|
TOMETICH, DANIELLE
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
A Prospective Study of the Impact of Breast Cancer on Symptoms and Functioning
|
5R01CA199137-04
|
$55,401
|
$55,401
|
AVIS, NANCY
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
A Prospective, Randomized Study to Compare Effects of Ulipristal Acetate with a Combined Oral Contraceptive on Breast Epithelial Cell Proliferation.
|
5R01CA200795-03
|
$406,451
|
$406,451
|
WESTHOFF, CAROLYN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
A Prototype Stationary X-Ray Source Digital Breast Tomosynthesis System
|
5R01CA214515-02
|
$349,610
|
$349,610
|
SCHWOEBEL, PAUL
|
SRI INTERNATIONAL
|
|
A Psychosocial Intervention to Improve Outcomes for Parents with Advanced Cancer
|
5K07CA218167-02
|
$176,839
|
$176,839
|
PARK, ELIZA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
A Quality Control Program for Quantitative MRI Data Acquisition and Analysis in Multi-site Clinical Trials
|
1R44CA235820-01
|
$224,422
|
$224,422
|
KARAULANOV, TODOR
|
QALIBREMD, INC.
|
Total relevant funding to Breast for this search: $379,307,131
|